BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 116524
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.116524
Table 3 Comparison between the two groups for the preoperative, operative, and postoperative variables
Variables
Group A (CU)
Group B (IC)
P value
Age62 (48-83)61 (51-73)0.59
BMI (kg/m2)24.65 (19.2-29.5)23.15 (20.8-30.2)0.468
eGFR (ml/minute)88.5 (16-113)98.5 (48-117)0.287
Preoperative hemoglobin (g/dL)10.7 (9-14.7)12.85 (10.5-16.3)0.056
Preoperative serum creatinine (mg/dL)1 (0.5-3.9)0.85 (0.5-1.6)0.361
Smoking13 (81.25%)10 (62.5%)0.433
Medical comorbidities6 (37.5%)6 (37.5%)> 0.999
Tumor stageT15 (31.25%)3 (18.75%)0.445
T25 (31.25%)12 (75%)
T36 (37.5%)1 (6.25%)
Tumor histopathologyUrothelial10 (62.5%)9 (56.25%)0.496
Squamous cell carcinoma2 (12.5%)1 (6.25%)
Adenocarcinoma1 (6.3%)0
Urothelial with variant3 (18.75%)6 (37.5%)
Neoadjuvant chemotherapy4 (25%)3 (18.75%)> 0.999
Neoadjuvant radiotherapy2 (12.5%)00.484
Intravesical BCG3 (18.8%)1 (6.3%)0.6
Operative time (minutes)360 (250-480)350 (270-500)0.985
Shunt time (minutes)60 (40-110)122.5 (90-165)< 0.001
Estimated blood loss (cc)950 (800-2000)900 (600-1600)0.171
Blood transfusion (units)2 (2-4)2 (1-4)0.184
Postoperative hemoglobin level (g/dL)10.15 (7.7-12.6)11.05 (8.9-13.6)0.029
Postoperative serum creatinine level (mg/dL)1.2 (0.6-3.3)1 (0.6-1.8)0.11
Hospital stay (days)10 (3-33)13 (9-55)0.08
Number of retrieved lymph nodes15.5 (4-28)20 (8-39)0.08
Perioperative complications15 (93.75%)16 (100%)> 0.999
Complication grade
No or low grades11 (68.75%)14 (87.5%)0.394
High grades5 (31.25%)2 (12.5%)
Days between appliance base changes15 (10-25)7 (5-15)< 0.001
Serum creatinine level at last follow-up (mg/dL)1.15 (0.9-4.1)1.1 (0.8-2.2)0.12
eGFR (mL/minute)70 (14-100)78 (33-101)0.186
Incidence of re-intervention0.4 (0.699)0.46 (0.66)> 0.999
Febrile UTI7 (63.63%)2 (14.28%)0.017
QoL score after 6 months68 (52-90)80.5 (62-103)0.029


Write to the Help Desk